Inspection Record

Lincoln Pharmaceuticals Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2025-02-03 5 findingsOther quality systemLabeling and packagingCleaning validationDeviation, CAPA, and investigationStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The recorded information or details were inadequate.

2Labeling and packaging

The implementation of minimum health and hygiene requirements for personnel was inadequate for ensuring the clean and sanitary fabrication, packaging, and/or labelling of drugs.

3Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

4Deviation, CAPA, and investigation

The evaluation was inadequate for cases where there was a deviation from the norm and/or where products were on the borderline of the acceptable range.

5Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-02-03. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Lincoln Pharmaceuticals Ltd. company profile — full history Health Canada documents, 2025 Go to Findings search